ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.23
-1.23%
US Tech 100
20,651.40
-1.20%
S&P 500
5,920.89
-0.84%
US Dollar vs CAD
1.43826
-0.15%
Bitcoin
92,003.89
-1.62%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Neovacs (ALNEV) Share Price

Neovacs

Neovacs (ALNEV)

EU
1.07
-0.05
(-4.46%)
Closed December 30 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.07
Bid
1.063
Ask
1.14
Volume
3,017
1.03 Day's Range 1.1598
0.0001 52 Week Range 3.20
Market Cap
332.356k
Previous Close
1.12
Open
1.11
Last Trade
90
@
1.07
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
32,731,039
Shares Outstanding
310,613
Dividend Yield
-
PE Ratio
-1,031,704.30
Earnings Per Share (EPS)
-28.15
Revenue
534k
Net Profit
-8.74M

About Neovacs

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.neovacs.com
Headquarters
Suresnes, Hauts-de-seine, Fra
Founded
-
Neovacs is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker ALNEV. The last closing price for Neovacs was 1.12 €. Over the last year, Neovacs shares have traded in a share price range of 0.0001 € to 3.20 €.

Neovacs currently has 310,613 shares outstanding. The market capitalization of Neovacs is 347,886.56 € . Neovacs has a price to earnings ratio (PE ratio) of -1031704.30.

Ask ADVFN Intelligence (AI)

ALNEV Latest News

More News

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE OPENING OF...

December 06 2019
GlobeNewswire Inc.

NEOVACS :

NEOVACS :   COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE L’OUVERTURE D’UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE Paris et Boston, le 27 novembre 2019 –...

November 27 2019
GlobeNewswire Inc.

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Paris et Boston, le 13 novembre 2019 – 18 : 00 CET - NÉOVACS...

November 13 2019
GlobeNewswire Inc.

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE   COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE POINT SUR LA SITUATION FINANCIÈRE DE LA...

November 08 2019
GlobeNewswire Inc.

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019 Paris et Boston, le 30 octobre 2019 – 17 : 45 CET - NÉOVACS (Euronext Paris : ALNEV), leader de l’immunothérapie active pour le...

October 30 2019
GlobeNewswire Inc.

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019   COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE   NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019   Paris et Boston, le...

October 02 2019
GlobeNewswire Inc.

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER PRESS RELEASE · PRESS RELEASE  · PRESS RELEASE NEOVACS ANNOUNCES APPOINTMENT OFVINCENT SERRA AS CHIEF EXECUTIVE...

September 30 2019
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-3.60360360361.111.20981.0311481.16197915DE
41.0697356566.6666670.00033.150.000270791520.00093551DE
121.06952139000.00053.150.0001327310390.00031839DE
261.05165715.21739130.01843.150.0001281269390.00111865DE
521.06985349000.00023.20.0001164830790.00156833DE
1561.06952139000.00054.3990.0001309822900.00245088DE
2601.0121744.827586210.0584.3990.0001644575820.00694661DE

ALNEV - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?
The current share price of Neovacs is 1.07 €
How many Neovacs shares are in issue?
Neovacs has 310,613 shares in issue
What is the market cap of Neovacs?
The market capitalisation of Neovacs is EUR 347.89k
What is the 1 year trading range for Neovacs share price?
Neovacs has traded in the range of 0.0001 € to 3.20 € during the past year
What is the PE ratio of Neovacs?
The price to earnings ratio of Neovacs is -1.03M
What is the cash to sales ratio of Neovacs?
The cash to sales ratio of Neovacs is 16.89M
What is the reporting currency for Neovacs?
Neovacs reports financial results in EUR
What is the latest annual turnover for Neovacs?
The latest annual turnover of Neovacs is EUR 534k
What is the latest annual profit for Neovacs?
The latest annual profit of Neovacs is EUR -8.74M
What is the registered address of Neovacs?
The registered address for Neovacs is 14, RUE DE LA REPUBLIQUE, SURESNES, HAUTS-DE-SEINE, 92150
What is the Neovacs website address?
The website address for Neovacs is www.neovacs.com
Which industry sector does Neovacs operate in?
Neovacs operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALENREntreprendre
8.05 €
(54.81%)
91
MLOCTOctopus Biosafety
0.182 €
(45.60%)
42.07k
MLWEYWeya
0.0185 €
(37.04%)
1,000
NACONNacon SA
0.76 €
(26.25%)
918.49k
CANDCandela Invest
1.46 €
(21.67%)
308
EIFDSTour Eiffel DS
0.012 €
(-34.78%)
55.37k
MLFTIFrance Tourisme Immobilier
0.028 €
(-21.13%)
3.44k
PROACProactis SA
0.0525 €
(-20.45%)
5k
ALTROTronic s Microsystems
4.02 €
(-19.60%)
28
ALNMRNamR SA
0.30 €
(-14.29%)
22.63k
ATOAtos SE
0.0025 €
(-7.41%)
2.59B
ALCYBCybergun
0.0001 €
(0.00%)
46.82M
BCPBanco Comercial Portugues SA
0.465 €
(1.04%)
46.42M
ALHPIHopium SA
0.0047 €
(-6.00%)
18.2M
EDPEDP SA
3.099 €
(-1.05%)
8.94M

Discussion

View Full Feed
saj saj 2 minutes ago
Come on BURU lets see 1.00
BURU
manibiotech manibiotech 2 minutes ago
You know well I didn't mean managing from clinical side . Assertion was obvious which management 
NWBO
AMB67 AMB67 2 minutes ago
Interim safety and efficacy data in January 2025?

December monthly report could contain human trial preliminary test results?

What tests are you all talking about?

Are you all talking about the results for the India based initial test phase involving fi
RDGL
tw0122 tw0122 2 minutes ago
$4.40
Holo at you again at $5s
HOLO
yadotn yadotn 2 minutes ago
MRNJ>>>$(70,084)>>>$(8,456,020)

MRNJ
OTCMarkets
PUBLISH DATE
November 13, 2024
"For the nine months ended September 30, 2024, the Company had a net loss of $70,084 (unaudited) and had an accumulated deficit of $8,456,020 (unaudited) as of September
MRNJ
dexprs dexprs 2 minutes ago
Alphabet's Options: A Look at What the Big Money is Thinking
BENZINGA 11:45 AM ET 12/30/2024
Investors with a lot of money to spend have taken a bullish stance on Alphabet .

And retail traders should know.

We noticed this today when the trades showed up o
Guido2 Guido2 3 minutes ago
Feel sorry for the fools who have been selling.
FNMA
yadotn yadotn 3 minutes ago
MRNJ>October, 2022>preparing>informing>819 Days

MRNJ
OTCMarkets
Press Release
October 3, 2022
“is pleased to announce that the Company is officially canceling any/all plans for the reverse split that was previously announced and filed with regulato
MRNJ
Acme Investments Acme Investments 3 minutes ago
Actually they was right!! Down 99.9 %....Nice dead cat bounce though!!
HMBL
glenn1919 glenn1919 3 minutes ago
holo......watt......wkey......https://stockcharts.com/h-sc/ui?s=holo&p=D&yr=0&mn=3&dy=0&id=p11960084343
vdog1776 vdog1776 3 minutes ago
Yeah I know I figured we would have 500 million traded today for tax losses! Hmmm kinda makes you wonder why we haven’t,,, does it?
VXIT
janice shell janice shell 3 minutes ago
You must be skipping posts:

https://www.seriouseats.com/alka-seltzer-cheese-sauce-recipe-8643844?hid=fad5c526ddce274b179d9d966a74cb9d69b23514&did=15888597-20241228&utm_source=seriouseats&utm_medium=email&utm_campaign=seriouseats_newsletter&utm_content=122824&lctg=fad5c526ddce274b179d9
Dickmo Dickmo 3 minutes ago
An excellent press release - not just for the company performance, but also for the human side of the business. Lots of reasons to be optimistic. Looking forward to a rewarding 2025.
IVDN
tdbowieknife tdbowieknife 4 minutes ago
See... unaudited, and GRLT still doesn't even have an auditor to even do an audit.


.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


..
GRLT
glenn1919 glenn1919 4 minutes ago
cney......zeo.....ctm......stem.....muln........................https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=3&dy=0&id=p11960084343
GREGG THE GREEK GREGG THE GREEK 4 minutes ago
.80s BURU
BURU
i_like_bb_stock i_like_bb_stock 4 minutes ago
7 years of nothing now its gonna go expert looks like truly disgusting
ASKH
Researchfyi Researchfyi 4 minutes ago
In la la land or in the land of Oz those facts exist. In Kansas, not so much. Your focus is so high up it’s in the clouds where the air is thin and reality gets clouded, where anything and any theories become possibilities. Come back down to earth for oxygen and a clearer picture of reality so that
LQMT
Number sleven Number sleven 5 minutes ago
JRoon,
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=201.66#:~:text=(2)%20Active%20ingredient%20means%20any,the%20specified%20activity%20or%20effect.
A self emulsifying version of vascepa would not contain a different active ingredient.
Sleven,
AMRN
jbsliverer jbsliverer 5 minutes ago
https://bsky.app/profile/charlesgaba.com/post/3lejyrpxjls23


.
rbb rbb 5 minutes ago
.80's
BURU
Stock_Barber Stock_Barber 5 minutes ago
Cut and paste forward looking statements from a company who has serious credibility issues with forward looking statements!

Posted over and over by 💩...

REALITY ➡️

ih.advfn.com/p.php?pid=chartscreenshot&u=2I8tZL3C0vEn15p2DPyqxY6dkEA7KuONqR%2FZxE4d
DBMM
JMCK6193 JMCK6193 6 minutes ago
🤡 show is just about done. 
P
U
M
P
T
A
R
D
S

Crying 😢 😭 
😆 🤣 😂 
VXIT
janice shell janice shell 6 minutes ago
Appalling. The price of mayo will rise.

Your Recent History

EU
ALNEV
Neovacs
BOV
BPFF11
Fundo Invest Imobiliario...
BIT
NSCIT8809823
International Bank for R...
BIT
I08995
Intesa Sanpaolo
BIT
I09021
Intesa Sanpaolo
AQSE
HMCH.GB
HSBC MSCI CHINA ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads